Giordano A, Tamiz A, Schiavo B, Rossi P
Minerva Med. 1979 Nov 17;70(51):3499-501.
In this study the anti-arrhythmic effectiveness of pindolol has been tested on ventricular effort arrhythmias in a group of 22 cardiopathic patients. The drug, administered for a week at the dose of 5 mg three times a day, obtained positive results due to its beta-blocking action and its intrinsic sympathomimetic activity.
在本研究中,对一组22名心脏病患者的室性应激性心律失常测试了吲哚洛尔的抗心律失常效果。该药物以每日三次、每次5毫克的剂量给药一周,因其β受体阻滞作用和内在拟交感神经活性而取得了阳性结果。